Antibody induction in mice by liposome-displayed recombinant enterotoxigenic Escherichia coli (ETEC) colonization antigens
© 2023 Chang Gung University. Publishing services by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)..
BACKGROUND: Enterotoxigenic Escherichia coli (ETEC) strains cause infectious diarrhea and colonize host intestine epithelia via surface-expressed colonization factors. Colonization factor antigen I (CFA/I), a prevalent ETEC colonization factor, is a vaccine target since antibodies directed to this fimbria can block ETEC adherence and prevent diarrhea.
METHODS: Two recombinant antigens derived from CFA/I were investigated with a vaccine adjuvant system that displays soluble antigens on the surface of immunogenic liposomes. The first antigen, CfaEB, is a chimeric fusion protein comprising the minor (CfaE) and major (CfaB) subunits of CFA/I. The second, CfaEad, is the adhesin domain of CfaE.
RESULTS: Owing to their His-tag, recombinant CfaEB and CfaEad, spontaneously bound upon admixture with nanoliposomes containing cobalt-porphyrin phospholipid (CoPoP), as well as a synthetic monophosphoryl lipid A (PHAD) adjuvant. Intramuscular immunization of mice with sub-microgram doses CfaEB or CfaEad admixed with CoPoP/PHAD liposomes elicited serum IgG and intestinal IgA antibodies. The smaller CfaEad antigen benefitted more from liposome display. Serum and intestine antibodies from mice immunized with liposome-displayed CfaEB or CfaEad recognized native CFA/I fimbria as evidenced by immunofluorescence and hemagglutination inhibition assays using the CFA/I-expressing H10407 ETEC strain.
CONCLUSION: These data show that colonization factor-derived recombinant ETEC antigens exhibit immunogenicity when delivered in immunogenic particle-based formulations.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
---|---|
Enthalten in: |
Biomedical journal - 46(2023), 6 vom: 22. Dez., Seite 100588 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhou, Shiqi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adhesins, Bacterial |
---|
Anmerkungen: |
Date Completed 25.12.2023 Date Revised 25.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.bj.2023.03.001 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM354306227 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM354306227 | ||
003 | DE-627 | ||
005 | 20231227140829.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.bj.2023.03.001 |2 doi | |
028 | 5 | 2 | |a pubmed24n1238.xml |
035 | |a (DE-627)NLM354306227 | ||
035 | |a (NLM)36925108 | ||
035 | |a (PII)S2319-4170(23)00025-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhou, Shiqi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Antibody induction in mice by liposome-displayed recombinant enterotoxigenic Escherichia coli (ETEC) colonization antigens |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.12.2023 | ||
500 | |a Date Revised 25.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 Chang Gung University. Publishing services by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). | ||
520 | |a BACKGROUND: Enterotoxigenic Escherichia coli (ETEC) strains cause infectious diarrhea and colonize host intestine epithelia via surface-expressed colonization factors. Colonization factor antigen I (CFA/I), a prevalent ETEC colonization factor, is a vaccine target since antibodies directed to this fimbria can block ETEC adherence and prevent diarrhea | ||
520 | |a METHODS: Two recombinant antigens derived from CFA/I were investigated with a vaccine adjuvant system that displays soluble antigens on the surface of immunogenic liposomes. The first antigen, CfaEB, is a chimeric fusion protein comprising the minor (CfaE) and major (CfaB) subunits of CFA/I. The second, CfaEad, is the adhesin domain of CfaE | ||
520 | |a RESULTS: Owing to their His-tag, recombinant CfaEB and CfaEad, spontaneously bound upon admixture with nanoliposomes containing cobalt-porphyrin phospholipid (CoPoP), as well as a synthetic monophosphoryl lipid A (PHAD) adjuvant. Intramuscular immunization of mice with sub-microgram doses CfaEB or CfaEad admixed with CoPoP/PHAD liposomes elicited serum IgG and intestinal IgA antibodies. The smaller CfaEad antigen benefitted more from liposome display. Serum and intestine antibodies from mice immunized with liposome-displayed CfaEB or CfaEad recognized native CFA/I fimbria as evidenced by immunofluorescence and hemagglutination inhibition assays using the CFA/I-expressing H10407 ETEC strain | ||
520 | |a CONCLUSION: These data show that colonization factor-derived recombinant ETEC antigens exhibit immunogenicity when delivered in immunogenic particle-based formulations | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Adjuvant | |
650 | 4 | |a Colonizing factor | |
650 | 4 | |a Diarrhea | |
650 | 4 | |a ETEC | |
650 | 4 | |a Liposomes | |
650 | 4 | |a Vaccine | |
650 | 7 | |a Liposomes |2 NLM | |
650 | 7 | |a Adhesins, Bacterial |2 NLM | |
650 | 7 | |a Antigens, Bacterial |2 NLM | |
700 | 1 | |a Yu, Karl O A |e verfasserin |4 aut | |
700 | 1 | |a Mabrouk, Moustafa T |e verfasserin |4 aut | |
700 | 1 | |a Jahagirdar, Dushyant |e verfasserin |4 aut | |
700 | 1 | |a Huang, Wei-Chiao |e verfasserin |4 aut | |
700 | 1 | |a Guerra, Julio A |e verfasserin |4 aut | |
700 | 1 | |a He, Xuedan |e verfasserin |4 aut | |
700 | 1 | |a Ortega, Joaquin |e verfasserin |4 aut | |
700 | 1 | |a Poole, Steven T |e verfasserin |4 aut | |
700 | 1 | |a Hall, Eric R |e verfasserin |4 aut | |
700 | 1 | |a Gomez-Duarte, Oscar G |e verfasserin |4 aut | |
700 | 1 | |a Maciel, Milton |c Jr |e verfasserin |4 aut | |
700 | 1 | |a Lovell, Jonathan F |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biomedical journal |d 2012 |g 46(2023), 6 vom: 22. Dez., Seite 100588 |w (DE-627)NLM225340402 |x 2320-2890 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2023 |g number:6 |g day:22 |g month:12 |g pages:100588 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bj.2023.03.001 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 46 |j 2023 |e 6 |b 22 |c 12 |h 100588 |